What restrictions on driving and operating machinery apply after Yescarta (axicabtagene ciloleucel) infusion?

After Yescarta (axicabtagene ciloleucel) infusion, patients must refrain from driving or operating heavy or potentially dangerous machines until at least 8 weeks after infusion or until neurological adverse reactions resolve, because neurological events, including altered mental status or seizures, may occur.